In view of the previous suggestion that plasma MIF levels are significantly higher in patients with type 2 diabetes than in healthy people [8, 9], we further compared plasma MIF levels in STEMI patients with or without diabetes mellitus. This evidence concerns the gene MIF and type 2 diabetes mellitus.